IFNγ identified as crucial for reducing pulmonary viral loads in COVID-19, new research shows Post author: Post published: December 14, 2023 Post category:uncategorized The role of type-2 interferon (IFNγ) in antiviral immunity. You Might Also Like New research identifies stress response as trigger for heart inflammation May 4, 2026 Exploring the link between maternal care and attachment in mouse pups October 27, 2025 FDA approves atezolizumab combination for stage III colon cancer with deficient DNA mismatch repair October 9, 2026
FDA approves atezolizumab combination for stage III colon cancer with deficient DNA mismatch repair October 9, 2026